DE69937347D1 - Regulierung der hämatopoietischen stammzelldifferenzierung durch verwendung von menschlichen mesenchymalen stammzellen - Google Patents
Regulierung der hämatopoietischen stammzelldifferenzierung durch verwendung von menschlichen mesenchymalen stammzellenInfo
- Publication number
- DE69937347D1 DE69937347D1 DE69937347T DE69937347T DE69937347D1 DE 69937347 D1 DE69937347 D1 DE 69937347D1 DE 69937347 T DE69937347 T DE 69937347T DE 69937347 T DE69937347 T DE 69937347T DE 69937347 D1 DE69937347 D1 DE 69937347D1
- Authority
- DE
- Germany
- Prior art keywords
- stem cells
- hematopoietic stem
- mesenchymal stem
- regulation
- human mesenchymal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0643—Osteoclasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/42—Organic phosphate, e.g. beta glycerophosphate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
- C12N2502/1352—Mesenchymal stem cells
- C12N2502/1358—Bone marrow mesenchymal stem cells (BM-MSC)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2503/00—Use of cells in diagnostics
- C12N2503/02—Drug screening
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/10—Mineral substrates
- C12N2533/18—Calcium salts, e.g. apatite, Mineral components from bones, teeth, shells
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8843198P | 1998-06-08 | 1998-06-08 | |
US88431P | 1998-06-08 | ||
US9923398P | 1998-09-04 | 1998-09-04 | |
US99233P | 1998-09-04 | ||
PCT/US1999/012847 WO1999064565A2 (en) | 1998-06-08 | 1999-06-08 | Regulation of hematopoietic stem cell differentiation by the use of human mesenchymal stem cells |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69937347D1 true DE69937347D1 (de) | 2007-11-29 |
DE69937347T2 DE69937347T2 (de) | 2008-09-04 |
Family
ID=26778653
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69937347T Expired - Lifetime DE69937347T2 (de) | 1998-06-08 | 1999-06-08 | Regulierung der hämatopoietischen stammzelldifferenzierung durch verwendung von menschlichen mesenchymalen stammzellen |
Country Status (12)
Country | Link |
---|---|
US (1) | US6255112B1 (de) |
EP (1) | EP1084230B1 (de) |
JP (1) | JP2003505006A (de) |
AT (1) | ATE375799T1 (de) |
AU (1) | AU4336499A (de) |
CA (2) | CA2330190C (de) |
CY (1) | CY1107121T1 (de) |
DE (1) | DE69937347T2 (de) |
DK (1) | DK1084230T3 (de) |
ES (1) | ES2296413T3 (de) |
PT (1) | PT1084230E (de) |
WO (1) | WO1999064565A2 (de) |
Families Citing this family (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001021766A2 (en) * | 1999-09-23 | 2001-03-29 | Cell Science Therapeutics | Methods and devices for obtaining non-hematopoietic lineage cells from hematopoietic progenitor cells |
WO2002040639A2 (en) * | 2000-11-14 | 2002-05-23 | The University Of Louisville Research Foundation, Inc. | Methods for enhancing engraftment of purified hematopoietic stem cells in allogeneic recipients |
MXPA03005014A (es) * | 2000-12-06 | 2004-09-10 | Robert J Hariri | Metodo para recolectar celulas madres de la placenta. |
US7311905B2 (en) | 2002-02-13 | 2007-12-25 | Anthrogenesis Corporation | Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells |
KR100973615B1 (ko) | 2001-02-14 | 2010-08-02 | 안트로제네시스 코포레이션 | 산후 포유류의 태반, 이의 용도 및 태반 줄기세포 |
MXPA03007175A (es) | 2001-02-14 | 2005-02-14 | Anthrogenesis Corp | Placenta de mamiferos postparto, su uso y celulas madres placentales extraidas de ella. |
MXPA04001166A (es) * | 2001-08-08 | 2004-05-20 | Schering Corp | Usos de citocina de mamifero; reactivos relacionados. |
AU2003213666A1 (en) * | 2002-03-02 | 2003-09-16 | Board Of Regents, The University Of Texas System | Local production and/or delivery of anti-cancer agents by stromal cell precursors |
US7498171B2 (en) * | 2002-04-12 | 2009-03-03 | Anthrogenesis Corporation | Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
US20040028660A1 (en) * | 2002-05-30 | 2004-02-12 | Anthrogenesis Corporation | Methods of using JNK or MKK inhibitors to modulate cell differentiation and to treat myeloproliferative disorders and myelodysplastic syndromes |
US20040028661A1 (en) * | 2002-08-07 | 2004-02-12 | Bartelmez Stephen H. | Expansion of cells using thrombopoietin and anti-transforming growth factor-beta |
EP1571910A4 (de) | 2002-11-26 | 2009-10-28 | Anthrogenesis Corp | Zytotherapeutika, zytotherapeutischeeinheiten und behandlungsverfahren, bei denen diese verwendet werden |
WO2004090112A2 (en) * | 2003-04-01 | 2004-10-21 | United States Of America Department Of Veteran's Affairs | Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction |
WO2004092402A1 (en) * | 2003-04-15 | 2004-10-28 | Pfizer Inc. | Dual reporter/dye reduction methodology for evaluating antiviral activity and cytotoxicity of hepatitis c virus inhibitors |
EP1479760A1 (de) * | 2003-05-19 | 2004-11-24 | ProBioGen AG | Künstliches Immunorgan |
US9453202B2 (en) | 2003-10-08 | 2016-09-27 | Vet-Stem, Inc. | Methods of preparing and using novel stem cell compositions and kits comprising the same |
US20050112551A1 (en) * | 2003-11-24 | 2005-05-26 | Agouron Pharmaceuticals, Inc. | Dual assay for evaluating activity and cytotoxicity of compounds in the same population of cells |
EP1799812A4 (de) | 2004-09-16 | 2009-09-09 | Gamida Cell Ltd | Verfahren zur ex-vivo-expansion von progenitor- und stammzellen durch gemeinsame kultivierung mit mesenchymzellen |
CA2512667A1 (en) * | 2005-01-07 | 2006-07-07 | Takahiro Ochiya | Human hepatocyte-like cells and uses thereof |
WO2006121445A2 (en) * | 2005-05-10 | 2006-11-16 | United States Of America Department Of Veteran's Affairs | Therapy of kidney diseases and multiorgan failure with mesenchymal stem cells and mesenchymal stem cell conditioned media |
KR101378874B1 (ko) | 2005-10-13 | 2014-03-27 | 안트로제네시스 코포레이션 | 태반 줄기세포를 이용한 면역 조절 |
US8846393B2 (en) * | 2005-11-29 | 2014-09-30 | Gamida-Cell Ltd. | Methods of improving stem cell homing and engraftment |
NZ595786A (en) | 2005-12-29 | 2013-05-31 | Anthrogenesis Corp | Placental stem cell populations |
WO2007079184A2 (en) | 2005-12-29 | 2007-07-12 | Anthrogenesis Corporation | Co-culture of placental stem cells and stem cells from a second source |
AU2007258514A1 (en) * | 2006-06-09 | 2007-12-21 | Anthrogenesis Corporation | Placental niche and use thereof to culture stem cells |
US7993918B2 (en) * | 2006-08-04 | 2011-08-09 | Anthrogenesis Corporation | Tumor suppression using placental stem cells |
KR100818213B1 (ko) | 2006-09-22 | 2008-04-01 | 재단법인서울대학교산학협력재단 | 파골세포 기반 적소 유사 구조에 의해 증식능이 증가된인간 제대혈 유래 다분화능 줄기 세포 및 그 제조방법 |
US20080118477A1 (en) * | 2006-11-09 | 2008-05-22 | Rush University Medical Center | Umbilical cord mesenchymal stem cells support cord blood hematopoiesis |
WO2008100497A1 (en) | 2007-02-12 | 2008-08-21 | Anthrogenesis Corporation | Hepatocytes and chondrocytes from adherent placental stem cells; and cd34+, cd45- placental stem cell-enriched cell populations |
NZ597779A (en) | 2007-02-12 | 2013-07-26 | Anthrogenesis Corp | Treatment of inflammatory diseases using placental stem cells |
US9200253B1 (en) | 2007-08-06 | 2015-12-01 | Anthrogenesis Corporation | Method of producing erythrocytes |
CN101173247B (zh) * | 2007-08-08 | 2010-06-02 | 中国人民解放军军事医学科学院基础医学研究所 | 一种利用间充质干细胞联合细胞因子培养破骨细胞的方法 |
DK2203176T3 (en) | 2007-09-28 | 2015-02-09 | Anthrogenesis Corp | Tumor suppression with human placental perfusate and human natural killer cells of an intermediate product from placenta |
CN102186338B (zh) | 2008-08-20 | 2016-03-16 | 人类起源公司 | 改进的细胞组合物及制备所述组合物的方法 |
AU2009283217B2 (en) | 2008-08-20 | 2015-09-17 | Celularity Inc. | Treatment of stroke using isolated placental cells |
CA2734446C (en) | 2008-08-22 | 2017-06-20 | Anthrogenesis Corporation | Methods and compositions for treatment of bone defects with placental cell populations |
NZ602455A (en) | 2008-11-19 | 2014-03-28 | Anthrogenesis Corp | Amnion derived adherent cells |
JP2012531916A (ja) | 2009-07-02 | 2012-12-13 | アンソロジェネシス コーポレーション | 支持細胞を用いない赤血球の生産方法 |
EP2454362A4 (de) * | 2009-07-14 | 2013-02-27 | Massachusetts Inst Technology | Hämatopoetische stromavorläuferzellen und verwendungen davon |
US9005967B2 (en) | 2010-01-22 | 2015-04-14 | Kyoto University | Myc variants improve induced pluripotent stem cell generation efficiency |
EP2529007B1 (de) | 2010-01-26 | 2017-07-12 | Anthrogenesis Corporation | Behandlung von knochenbedingten karzinomen mit plazentastammzellen |
TWI578993B (zh) | 2010-04-07 | 2017-04-21 | 安瑟吉納西斯公司 | 利用胎盤幹細胞之血管新生 |
WO2011127113A1 (en) | 2010-04-08 | 2011-10-13 | Anthrogenesis Corporation | Treatment of sarcoidosis using placental stem cells |
ES2666746T3 (es) | 2010-07-13 | 2018-05-07 | Anthrogenesis Corporation | Métodos para generar linfocitos citolíticos naturales |
EP2625577B1 (de) | 2010-10-08 | 2019-06-26 | Terumo BCT, Inc. | Anpassbares verfahren und systeme für züchtung und ernte von zellen in einem hohlfaser-bioreaktorsystem |
US9506039B2 (en) | 2010-12-03 | 2016-11-29 | Kyoto University | Efficient method for establishing induced pluripotent stem cells |
WO2012092485A1 (en) | 2010-12-31 | 2012-07-05 | Anthrogenesis Corporation | Enhancement of placental stem cell potency using modulatory rna molecules |
EP3443968A1 (de) | 2011-06-01 | 2019-02-20 | Celularity, Inc. | Schmerzbehandlung mithilfe von stammzellen aus der plazenta |
WO2013055476A1 (en) | 2011-09-09 | 2013-04-18 | Anthrogenesis Corporation | Treatment of amyotrophic lateral sclerosis using placental stem cells |
BR112014020119A2 (pt) | 2012-02-13 | 2020-10-27 | Gamida-Cell Ltd | cultura de células-tronco mesenquimais |
US9567569B2 (en) | 2012-07-23 | 2017-02-14 | Gamida Cell Ltd. | Methods of culturing and expanding mesenchymal stem cells |
US9175266B2 (en) | 2012-07-23 | 2015-11-03 | Gamida Cell Ltd. | Enhancement of natural killer (NK) cell proliferation and activity |
CN105142651A (zh) | 2013-02-05 | 2015-12-09 | 人类起源公司 | 来自胎盘的自然杀伤细胞 |
EP3569699A1 (de) | 2013-09-04 | 2019-11-20 | Otsuka Pharmaceutical Factory, Inc. | Verfahren zur herstellung pluripotenter stammzellen |
WO2015073913A1 (en) | 2013-11-16 | 2015-05-21 | Terumo Bct, Inc. | Expanding cells in a bioreactor |
EP3122866B1 (de) | 2014-03-25 | 2019-11-20 | Terumo BCT, Inc. | Passives ersetzen von medien |
US20160090569A1 (en) | 2014-09-26 | 2016-03-31 | Terumo Bct, Inc. | Scheduled Feed |
KR101566450B1 (ko) * | 2015-04-03 | 2015-11-05 | (유)스템메디케어 | 중간엽 줄기세포에서 단백질의 대량 생산 방법 |
WO2017004592A1 (en) | 2015-07-02 | 2017-01-05 | Terumo Bct, Inc. | Cell growth with mechanical stimuli |
US11104874B2 (en) | 2016-06-07 | 2021-08-31 | Terumo Bct, Inc. | Coating a bioreactor |
US11685883B2 (en) | 2016-06-07 | 2023-06-27 | Terumo Bct, Inc. | Methods and systems for coating a cell growth surface |
US11624046B2 (en) | 2017-03-31 | 2023-04-11 | Terumo Bct, Inc. | Cell expansion |
JP7393945B2 (ja) | 2017-03-31 | 2023-12-07 | テルモ ビーシーティー、インコーポレーテッド | 細胞増殖 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5399493A (en) * | 1989-06-15 | 1995-03-21 | The Regents Of The University Of Michigan | Methods and compositions for the optimization of human hematopoietic progenitor cell cultures |
US5486359A (en) * | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
DE4322570C1 (de) * | 1993-07-07 | 1994-06-16 | Gsf Forschungszentrum Umwelt | Stromale Zellinien aus menschlichem Knochenmark |
US5719058A (en) * | 1995-04-10 | 1998-02-17 | Merck & Co., Inc. | Method for producing a highly enriched population of osteoclast cells |
-
1999
- 1999-06-08 CA CA002330190A patent/CA2330190C/en not_active Expired - Fee Related
- 1999-06-08 ES ES99955496T patent/ES2296413T3/es not_active Expired - Lifetime
- 1999-06-08 EP EP99955496A patent/EP1084230B1/de not_active Expired - Lifetime
- 1999-06-08 DK DK99955496T patent/DK1084230T3/da active
- 1999-06-08 WO PCT/US1999/012847 patent/WO1999064565A2/en active IP Right Grant
- 1999-06-08 JP JP2000553555A patent/JP2003505006A/ja active Pending
- 1999-06-08 CA CA002680649A patent/CA2680649A1/en not_active Abandoned
- 1999-06-08 AU AU43364/99A patent/AU4336499A/en not_active Abandoned
- 1999-06-08 US US09/327,796 patent/US6255112B1/en not_active Expired - Lifetime
- 1999-06-08 PT PT99955496T patent/PT1084230E/pt unknown
- 1999-06-08 DE DE69937347T patent/DE69937347T2/de not_active Expired - Lifetime
- 1999-06-08 AT AT99955496T patent/ATE375799T1/de not_active IP Right Cessation
-
2008
- 2008-01-02 CY CY20081100007T patent/CY1107121T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
WO1999064565A2 (en) | 1999-12-16 |
EP1084230A2 (de) | 2001-03-21 |
CA2330190A1 (en) | 1999-12-16 |
AU4336499A (en) | 1999-12-30 |
WO1999064565A9 (en) | 2000-04-13 |
CA2330190C (en) | 2009-12-22 |
CA2680649A1 (en) | 1999-12-16 |
US6255112B1 (en) | 2001-07-03 |
ES2296413T3 (es) | 2008-04-16 |
PT1084230E (pt) | 2008-01-25 |
CY1107121T1 (el) | 2012-10-24 |
DK1084230T3 (da) | 2008-03-03 |
DE69937347T2 (de) | 2008-09-04 |
JP2003505006A (ja) | 2003-02-12 |
ATE375799T1 (de) | 2007-11-15 |
WO1999064565A3 (en) | 2000-02-24 |
EP1084230B1 (de) | 2007-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69937347D1 (de) | Regulierung der hämatopoietischen stammzelldifferenzierung durch verwendung von menschlichen mesenchymalen stammzellen | |
WO2000006705A3 (de) | Genetisch modifizierte cd34-negative, adhärent wachsende stammzellen und deren verwendung in der gentherapie | |
KR100339316B1 (de) | ||
MY140230A (en) | Activating expression of an amplifying endogenous gene by homologous recombination | |
SE0201328D0 (sv) | Hematopoietic differentiation of human embryonic stem cells | |
DE69127313T2 (de) | Subklasse von menschlichen Vorläuferzellen | |
ATE400651T1 (de) | Verwendung von grünem fluoreszenzprotein | |
AU2126688A (en) | Serum free media for the growth of insect cells and expression of products thereby | |
DE60017875D1 (de) | Verwendung von collagenase in der zubereitung von neuralen stammzellkulturen | |
IL164817A (en) | Composition comprising near diploid immortalized keratinocytes cells | |
DE69033961T2 (de) | Zellinien, die einen biologisch aktiven faktor-ix exprimieren | |
ATE243741T1 (de) | Zufuhr von genprodukten mittels mesangium-zellen | |
Jun-Jiang et al. | Vascular endothelial growth factor 165-transfected adipose-derived mesenchymal stem cells promote vascularization-assisted fat transplantation | |
ATE191501T1 (de) | Verwendung von hepatocyten-wachstumsfaktoren zur herstellung eines vermehrungssystems für hematopoietische stammzellen | |
EP0808364A4 (de) | Menschliche pancreas zellinien: entwiklungen und anwendungen | |
GB2366291A (en) | A transformant for screening of inhibitors for human immnodeficiency virus | |
AU4216599A (en) | Hematopoietic progenitor cell gene transduction | |
DE69823813D1 (de) | Malignitätsunterdrückung durch verwendung von ribonucleotid reductase r1 | |
Whitson et al. | The isolation and primary culture of putative human root odontoblasts. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8328 | Change in the person/name/address of the agent |
Representative=s name: DR. VOLKER VOSSIUS, CORINNA VOSSIUS, TILMAN VOSSIU |
|
8364 | No opposition during term of opposition |